5% GLUCOSE INJECTION

Manufacturer
Baxter Healthcare Corporation | Baxter Healthcare (Shanghai) Co. Ltd.
Effective date
2025-01-24
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-01 20:41:45

Label at a glance#

ProductGlucose
Active ingredientDEXTROSE MONOHYDRATE
Label structure3 sections

Label contents#

Full prescribing information#

HEALTH CARE PROFESSIONAL LETTER

HEALTH CARE PROVIDER LETTER SECTION

DHCP Letter 1.jpg
DHCP Letter 1.jpg
DHCP Letter 2.jpg
DHCP Letter 2.jpg
DHCP Letter 3.jpg
DHCP Letter 3.jpg

Reporting Adverse Events or Product Quality Issues
To report adverse events associated with these imported products, please call Baxter at 1-866-888-2472, or fax: 1- 800-759-1801. Adverse events or quality problems experienced with the use of these imported products may also be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax:
• Complete and submit the report Online: www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program
• Regular mail or Fax: Download form www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

To report product quality issues associated with these imported products, please contact Baxter Product Surveillance through Baxter - Product Feedback Portal (productfeedback.baxter.com/%22%20/o%20%22https:/productfeedback.baxter.com/%22%20/t%20%22_blank).

Please also refer to the local prescribing information of the imported product, translated into English, available for:
• 0.9% Sodium Chloride Injection (click nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723233)
• 5% Glucose Injection (click nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723235)
• 10% Glucose Injection (click nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723237)
• 5% Glucose/0.9% Sodium Chloride Injection (click nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723238)

Please refer to the FDA-approved prescribing information for each drug product listed below:
• 0.9% Sodium Chloride Injection USP (click www.dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=f55bd888-5e01-474d-871b-24654c070178&type=pdf&name=f55bd888-5e01-474d-871b-24654c070178)
• 5% Dextrose Injection USP (click www.dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5&type=pdf&name=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5)
• 10% Dextrose Injection USP (click www.dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5&type=pdf&name=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5)
• 5% Dextrose/0.9% Sodium Chloride Injection USP (click www.accessdata.fda.gov/drugsatfda_docs/label/2019/016678s007,016683s103,016687s104,016689s107,016697s098lbl.pdf)

DHCP Letter 4.jpg
DHCP Letter 4.jpg
DHCP Letter 5.jpg
DHCP Letter 5.jpg
DHCP Letter 6.jpg
DHCP Letter 6.jpg
DHCP Letter 7.jpg
DHCP Letter 7.jpg
DHCP Letter 8.jpg
DHCP Letter 8.jpg
DHCP Letter 9.jpg
DHCP Letter 9.jpg
DHCP Letter 10.jpg
DHCP Letter 10.jpg
DHCP Letter 11.jpg
DHCP Letter 11.jpg

PACKAGE INSERT

SPL UNCLASSIFIED SECTION

SPC302US Image 1.jpg
SPC302US Image 1.jpg
SPC302US Image 2.jpg
SPC302US Image 2.jpg
SPC302US Image 3.jpg
SPC302US Image 3.jpg
SPC302US Image 4.jpg
SPC302US Image 4.jpg
SPC305US Image 1.jpg
SPC305US Image 1.jpg
SPC305US Image 2.jpg
SPC305US Image 2.jpg
SPC305US Image 3.jpg
SPC305US Image 3.jpg
SPC305US Image 4.jpg
SPC305US Image 4.jpg

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

A6C0062US Representative Carton Label.jpg
A6C0062US Representative Carton Label.jpg
A6C0062US Representative Carton Label 2.jpg
A6C0062US Representative Carton Label 2.jpg

Baxter Logo Trademark

A6C0062US

GLUCOSE INJECTION

50

100

150

200

250ml
5% GLUCOSE

[Strength] 250ml: 12.5g
[Description] This product is a colorless or almost
colorless clear liquid
[Dosage and Administration] Intravenous drip See the
package insert for details
For details of [Indications], [Adverse Reactions],
[Contraindications], and [Precautions], please refer to the
package insert

[Storage] Store in overwrap

The solution should be clear and should be used
up at one time
Inspect the inner bag by squeezing it and discard
solution if leakage occurs
License Number: H19994071

AA

[Drug Marketing Authorization Holder] [Manufacturer]
Name: Baxter Healthcare (Shanghai) Co., Ltd.
Address: No. 388, Tingzhu Road, Jinshan District, Shanghai

BarCode
(01) 00303389795018

LOT
MFG
EXP

5% Glucose Injection

250ml X 40

LOT S0000000 EXP YYYY-MM
A6C0062US 1C/N LIC H19994071

5% Glucose Injection

250ml X 40

LOT S0000000 EXP YYYY-MM
MFG YYYY-MM-DD 1C/N 0000

A6C0064US Representative Carton Label 1
A6C0064US Representative Carton Label 1
A6C0064US Representative Carton Label 2.jpg
A6C0064US Representative Carton Label 2.jpg

Baxter Logo Trademark

A6C0064US

GLUCOSE INJECTION

100

200

300

400

500

600

700

800

900

1000ml
5% GLUCOSE

[Strength] 1000ml: 50g
[Description] This product is a colorless or almost
colorless clear liquid
[Dosage and Administration] Intravenous drip See the
package insert for details
For details of [Indications], [Adverse Reactions],
[Contraindications], and [Precautions], please refer to the
package insert

[Storage] Store in overwrap

The solution should be clear and should be used
up at one time
Inspect the inner bag by squeezing it and discard
solution if leakage occurs
License Number: H19983151

AA

[Drug Marketing Authorization Holder] [Manufacturer]
Name: Baxter Healthcare (Shanghai) Co., Ltd.
Address: No. 388, Tingzhu Road, Jinshan District, Shanghai

BarCode
(01) 00303389801016

LOT
MFG
EXP

5% Glucose Injection

1000ml X 12

LOT S0000000 EXP YYYY-MM
A6C0064US 1C/N LIC H19983151

5% Glucose Injection

1000ml X 12

LOT S0000000 EXP YYYY-MM
MFG YYYY-MM-DD 1C/N 0000

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0338-9795GLUCOSE (DEXTROSE ANHYDROUS) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION]3Unmatched20250130_40c99503-14fd-4cd1-b073-c1af7bfa3229.zip
0338-9801GLUCOSE (DEXTROSE ANHYDROUS) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION]3Unmatched20250130_40c99503-14fd-4cd1-b073-c1af7bfa3229.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0338-97950338-9795-01, 0338-9795-40
0338-98010338-9801-01, 0338-9801-12

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ec439628-0781-4170-b4ed-41b2e3f2990440c99503-14fd-4cd1-b073-c1af7bfa32292025-01-24Exact identifier
spl set id: 40c99503-14fd-4cd1-b073-c1af7bfa3229

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.